Evidence for non-covalent clusters of the c-met proto-oncogene product

scientific article published on June 1, 1992

Evidence for non-covalent clusters of the c-met proto-oncogene product is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID1317541

P50authorIlan TsarfatyQ111524904
P2093author name stringT. Suzuki
G. F. Vande Woude
D. L. Faletto
M. Gonzatti
T. E. Kmiecik
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectproto-oncogeneQ30555
P304page(s)1149-1157
P577publication date1992-06-01
P1433published inOncogeneQ1568657
P1476titleEvidence for non-covalent clusters of the c-met proto-oncogene product
P478volume7

Reverse relations

cites work (P2860)
Q27647900A mechanistic basis for converting a receptor tyrosine kinase agonist to an antagonist
Q34426051A tandem repeat of a fragment of Listeria monocytogenes internalin B protein induces cell survival and proliferation
Q47303095Activated HGF-c-Met Axis in Head and Neck Cancer
Q40667298Activated c-Met signals through PI3K with dramatic effects on cytoskeletal functions in small cell lung cancer.
Q36595980Activating mutations for the met tyrosine kinase receptor in human cancer
Q42263223Association of integrin beta1 and c-MET in mediating EGFR TKI gefitinib resistance in non-small cell lung cancer
Q37404891Cellular adherence elicits ligand-independent activation of the Met cell-surface receptor
Q27635335Crystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor.
Q36710400Current understanding of the molecular mechanisms of kidney cancer: a primer for urologists
Q36565319Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway
Q34584046Dysregulation of Met receptor tyrosine kinase activity in invasive tumors
Q50977853Hepatocyte Growth Factor Isoforms in Tissue Repair, Cancer, and Fibrotic Remodeling.
Q35070072In vivo direct molecular imaging of early tumorigenesis and malignant progression induced by transgenic expression of GFP-Met
Q33566681MAPK pathway inhibition induces MET and GAB1 levels, priming BRAF mutant melanoma for rescue by hepatocyte growth factor
Q38167461MET receptor tyrosine kinase as an autism genetic risk factor
Q53483428Molecular mechanism of stomach carcinogenesis.
Q34236834Non-agonistic bivalent antibodies that promote c-MET degradation and inhibit tumor growth and others specific for tumor related c-MET.
Q34753763Single-molecule photobleaching reveals increased MET receptor dimerization upon ligand binding in intact cells
Q38431115Structural Basis of TPR-Mediated Oligomerization and Activation of Oncogenic Fusion Kinases.
Q41969702Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer
Q36705281Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor

Search more.